United States · Funded startup

Who invested in Rapid Pathogen Screening

4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$56Mraised across 4 rounds since 2010, from 4 sources

$15MDebt$6.8MVenture$6.3MDebt$28MDebt
Latest round
Debt, $28MOct 2014
Step-upi
4.5×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20102011201220132014
$15MDebt$6.8MVenture$6.3MDebt$28MDebt
First round
Debt, $15M
Feb 2010
Biggest round
$28M
Debt · Oct 2014
Usual gap between rounds
15 months
the median of 3

The rounds

  1. Oct 2014
    Debt$28M1 new

    From a historical funding record

  2. Jul 2013
    Debt$6.3M

    No investor was named in the report.

    Reported by sec.govSEC filing: $2.3M sold, first sale Oct 2012

  3. Oct 2012
    Venture$6.8M

    No investor was named in the report.

    Reported by sec.govSEC filing: $6.8M sold, first sale Sept 2010

  4. Feb 2010
    Debt$15M

    No investor was named in the report.

    From a historical funding recordSEC filing: $15M sold, first sale Jan 2009

Funding filed with regulators

Rapid Pathogen Screening filed 4 raises, $30M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jul 2013$6.3M1 investordebt, options, securities on exerciseof $10M offeredSEC Form D
  2. Oct 2012$2.3M25 investorsequityof $15M offeredSEC Form D
  3. Sept 2010$6.8M57 investorsequityof $22M offeredSEC Form D
  4. Jan 2009$15M71 investorsequity, debtSEC Form D

Founders and team

From the SEC filings it signed: 3 on the team.

  • J. Scott WombleExecutive Officeri
  • Robert SamburskyExecutive Officer, Directori
  • Robert VanDineExecutive Officer, Directori

On the board, as filediCaroline T. PopperCharles T. SaldariniDaniel SamburskyJules MusingerStephen R. La NeveThomas Orsini

Everyone who backed them

OrbiMedPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rapid Pathogen Screening

Who invested in Rapid Pathogen Screening?

Rapid Pathogen Screening's investors include OrbiMed.

How much has Rapid Pathogen Screening raised?

Rapid Pathogen Screening has raised $56M across 4 rounds since 2010.

When did Rapid Pathogen Screening last raise?

Rapid Pathogen Screening's most recent round was a Debt of $28M in Oct 2014.

What was Rapid Pathogen Screening's biggest round?

Its most recent round, $28M in Oct 2014, is also its largest on record.

Who backed Rapid Pathogen Screening first?

Rapid Pathogen Screening's first round on record, in Oct 2014, was backed by OrbiMed.

What stage is Rapid Pathogen Screening at?

Rapid Pathogen Screening's latest named round is a Debt, in Oct 2014.

Where is Rapid Pathogen Screening based?

Rapid Pathogen Screening is based in the United States.

Companies like Rapid Pathogen Screening

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.